That's pretty substantial. Obviously no one knows what Phase 3 will show, but cynicism seems unwarranted at this point.
https://investor.lilly.com/news-releases/news-release-detail...
I'd honestly be more assured if there was anything other than pure self assessed speculation at play here, and again, if Eli Lilly clearly wasn't using this article to bully smaller players in the space. You know, before they even have a released product.
This is called hacker news but the hacker mentality is almost entirely missing here.
[1] https://www.thelancet.com/journals/lancet/article/PIIS0140-6...
The posted article is marketing and not journalism. I have learned absolutely nothing from it. It seeks to manipulate a market before the product is even released.
> but mindless cynicism hardly seems warranted.
I'm sorry that you're unwilling to consider any facts outside of your very narrow view. That does not make my comments cynical nor mindless. There does seem to be an intentional mindlessness in pretending that any of this is beyond your understanding.
When the news is this fast and loose with anything that even looks like a fact how am I not to see this as rank manipulation? There is nothing critical in this article except for how hard doctors and insurance companies might be pressed to prescribe it.
Then they end with this gem:
"But Seigerman said it will also put pressure on smaller companies developing pills, such as Structure Therapeutics, to find a partner that can help them compete in the weight loss drug market with pharmaceutical behemoths like Eli Lilly. "
Oh. I see. It's not just manipulation but dumb protectionist gate keeping.
Depressing.